{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05416307",
            "orgStudyIdInfo": {
                "id": "ELA026-CP002"
            },
            "organization": {
                "fullName": "Electra Therapeutics Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Evaluation of the Safety and Efficacy of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis",
            "officialTitle": "An Open-label, Single-arm, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Multiple Doses of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "evaluation-of-the-safety-and-efficacy-of-in-participants-with-secondary-hemophagocytic-lymphohistiocytosis"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-05-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-06-06",
            "studyFirstSubmitQcDate": "2022-06-08",
            "studyFirstPostDateStruct": {
                "date": "2022-06-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-08",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-09",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Electra Therapeutics Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Hemophagocytic lymphohistiocytosis is a rare, aggressive and life-threatening syndrome of excessive immune activation. ELA026 is a fully human IgG1 SIRP-directed monoclonal antibody designed to reduce the myeloid and T cells driving the inflammation. The purpose of this study is to assess the safety, efficacy pharmacokinetics and pharmacodynamics of ELA026 in participants with secondary hemophagocytic lymphohistiocytosis.",
            "detailedDescription": "This study is an open-label, single arm, multicenter interventional study, comprised of 4 cohorts; a dose escalating cohort (cohort 1) followed by 3 fixed dose cohorts (Cohorts 2-4). Newly diagnosed and previously treated participants with secondary hemophagocytic lymphohistiocytosis will be enrolled and treated over 12-weeks. Secondary hemophagocytic lymphohistiocytosis is the most common form of this disease and is typically associated with several other clinical conditions (eg, malignancy associated HLH (m-HLH), infection, or autoimmune disease)."
        },
        "conditionsModule": {
            "conditions": [
                "Secondary Hemophagocytic Lymphohistiocytosis (sHLH)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 24,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "ELA026",
                    "type": "EXPERIMENTAL",
                    "description": "Cohort 1: Single dose escalation up to 3.0 mg/kg IV or SC\n\nCohorts 2-4: dose, route, and frequency of administration (IV or SC) to be determined",
                    "interventionNames": [
                        "Drug: ELA026"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "ELA026",
                    "description": "Single or multiple daily doses of ELA026",
                    "armGroupLabels": [
                        "ELA026"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of Treatment-Emergent Adverse Events [Safety and tolerability]",
                    "description": "Incidence of adverse events (AEs) including dose-limiting toxicities (DLTs), serious adverse events (SAEs), deaths, AEs leading to withdrawal from study",
                    "timeFrame": "By week 12"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Best Response to Treatment",
                    "description": "Achievement of a complete response (CR), modified complete response (mCR), partial response (PR) or HLH improvement",
                    "timeFrame": "By week 4"
                },
                {
                    "measure": "Plasma concentrations of ELA026",
                    "timeFrame": "Baseline to week 12"
                },
                {
                    "measure": "Change from baseline in monocyte levels",
                    "timeFrame": "Baseline to week 12"
                },
                {
                    "measure": "Incidence of Anti-drug antibodies to ELA026",
                    "timeFrame": "Baseline to week 12"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n1. \u226512 years at the time of HLH diagnosis (Cohort 1)\n2. \u22656 years at the time of HLH diagnosis (Cohort 2-4)\n3. Treatment na\u00efve OR\n4. Early refractory sHLH\n5. Participant with sHLH confirmed criteria based on ful\ufb01lling 5 out of 8 HLH-2004 diagnostic criteria.\n\nKey Exclusion Criteria:\n\n1. Known or previous treatment for primary HLH\n2. Any other signi\ufb01cant concurrent, uncontrolled medical condition that in the opinion of the Investigator contraindicates participation in this study\n3. Unknown trigger for sHLH\n4. Active, relapsed/refractory malignancy for which no suitable therapies are available to treat the malignancy triggering the HLH\n5. Allogeneic hemopoietic stem cell transplant (HSCT) within 100 days of the first dose of ELA026.\n6. Ongoing administration of any therapies used to treat HLH (excluding dexamethasone)\n7. Live or attenuated vaccine received within 6 weeks or bacille Calmette-Guerin (BCG) vaccine within 12 weeks prior to Screening",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "6 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Clinical Trials",
                    "role": "CONTACT",
                    "phone": "650-466-8041",
                    "email": "clinicaltrials@electra-therapeutics.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Medical Director",
                    "affiliation": "Electa Therapeutics Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Alabama",
                    "status": "RECRUITING",
                    "city": "Birmingham",
                    "state": "Alabama",
                    "zip": "35294",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.52066,
                        "lon": -86.80249
                    }
                },
                {
                    "facility": "Phoenix Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Phoenix",
                    "state": "Arizona",
                    "zip": "85016",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.44838,
                        "lon": -112.07404
                    }
                },
                {
                    "facility": "University of California, Los Angeles",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "MedStar Georgetown",
                    "status": "RECRUITING",
                    "city": "Washington",
                    "state": "District of Columbia",
                    "zip": "20007",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.89511,
                        "lon": -77.03637
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "MD Anderson",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Texas Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Medizinische Universit\u00e4t Innsbruck",
                    "status": "WITHDRAWN",
                    "city": "Innsbruck",
                    "country": "Austria",
                    "geoPoint": {
                        "lat": 47.26266,
                        "lon": 11.39454
                    }
                },
                {
                    "facility": "Medical University of Vienna",
                    "status": "RECRUITING",
                    "city": "Vienna",
                    "country": "Austria",
                    "geoPoint": {
                        "lat": 48.20849,
                        "lon": 16.37208
                    }
                },
                {
                    "facility": "Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico",
                    "status": "RECRUITING",
                    "city": "Milan",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Bambino Gesu' Roma",
                    "status": "WITHDRAWN",
                    "city": "Roma",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 41.89193,
                        "lon": 12.51133
                    }
                },
                {
                    "facility": "Amsterdam UMC",
                    "status": "RECRUITING",
                    "city": "Amsterdam",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 52.37403,
                        "lon": 4.88969
                    }
                },
                {
                    "facility": "Erasmus UMC",
                    "status": "RECRUITING",
                    "city": "Rotterdam",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 51.9225,
                        "lon": 4.47917
                    }
                },
                {
                    "facility": "Hospital 12 de Octubre, Madrid",
                    "status": "WITHDRAWN",
                    "city": "Madrid",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Ramon y Cajal",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital La Fe Valencia",
                    "status": "WITHDRAWN",
                    "city": "Valencia",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 39.46975,
                        "lon": -0.37739
                    }
                },
                {
                    "facility": "University College London Hospitals",
                    "status": "RECRUITING",
                    "city": "London",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009362",
                    "term": "Neoplasm Metastasis"
                },
                {
                    "id": "D000051359",
                    "term": "Lymphohistiocytosis, Hemophagocytic"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009385",
                    "term": "Neoplastic Processes"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000015616",
                    "term": "Histiocytosis, Non-Langerhans-Cell"
                },
                {
                    "id": "D000015614",
                    "term": "Histiocytosis"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12307",
                    "name": "Neoplasm Metastasis",
                    "asFound": "Secondary",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26695",
                    "name": "Lymphohistiocytosis, Hemophagocytic",
                    "asFound": "Hemophagocytic Lymphohistiocytosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12330",
                    "name": "Neoplastic Processes",
                    "relevance": "LOW"
                },
                {
                    "id": "M18216",
                    "name": "Histiocytosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M18218",
                    "name": "Histiocytosis, Non-Langerhans-Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4155",
                    "name": "Non-Langerhans-Cell Histiocytosis",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}